Medline Inc. MDLN
39.16 USD +1.48 (+3.93%)
Regular-session close
38.98 -0.18 -0.46%
After hours · Nov 18, 7:23 PM ET
36.75 Day range 39.41
31.37 52-week range 50.88
- YTD
- -6.76%
- 1 year
- -4.49%
News
prnewswire.com Medline launches right-sized Ranpak packaging solutions in two key distribution centers Facilities in Grayslake, Ill., and Katy, Texas, helping to make healthcare run better NORTHFIELD, Ill.
globenewswire.com MDLN Investigation: Medline is being Investigated for Securities Fraud Following Product Quality Issues – Contact BFA Law if You Lost Money NEW YORK, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
globenewswire.com Medline Inc. announces pricing of secondary offering of Class A common stock NORTHFIELD, Ill., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today the pricing of its secondary offering of 60,000,000 shares of Medline's Class A common…
defenseworld.net 3,741,918 Medline $MDLN Shares Sold by Bessemer Group Inc. Bessemer Group Inc. lowered its holdings in Medline (NASDAQ: MDLN) by 66.2% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor…
globenewswire.com Medline Inc. announces launch of secondary offering of Class A common stock NORTHFIELD, Ill., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc.…benzinga.com Medline Files Prospectus For Secondary Offering of 60M Shares On Behalf Of Selling Shareholders; To Repurchase $200M Of Stock From Selling Shareholders At Assumed Price Of $39.47/Share The selling stockholders named in this prospectus are offering 60,000,000 shares of our Class A common stock. Our shares of Class A common stock are listed on the Nasdaq Global Select Market…
globenewswire.com MDLN Securities Notice: Medline Investors that Suffered Losses when Stock Plummeted 13% are Notified to Contact BFA Law about its Securities Fraud Investigation NEW YORK, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
defenseworld.net Medline (NASDAQ:MDLN) Stock Has Average Target Price of $46.08 Shares of Medline (NASDAQ: MDLN - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the twenty-nine ratings firms that are covering the firm, MarketBeat.com reports.…benzinga.com UBS Maintains Buy on Medline, Raises Price Target to $49 UBS analyst Kevin Caliendo maintains Medline (NASDAQ:MDLN) with a Buy and raises the price target from $43 to $49.
benzinga.com Citigroup Maintains Buy on Medline, Raises Price Target to $47 Citigroup analyst Joanne Wuensch maintains Medline (NASDAQ:MDLN) with a Buy and raises the price target from $45 to $47.
benzinga.com Leerink Partners Maintains Outperform on Medline, Raises Price Target to $46 Leerink Partners analyst Michael Cherny maintains Medline (NASDAQ:MDLN) with a Outperform and raises the price target from $43 to $46.
benzinga.com Evercore ISI Group Maintains Outperform on Medline, Raises Price Target to $44 Evercore ISI Group analyst Elizabeth Anderson maintains Medline (NASDAQ:MDLN) with a Outperform and raises the price target from $38 to $44.
marketbeat.com Medline Q3 Earnings Call Highlights Medline NASDAQ: MDLN reported third-quarter revenue growth of 10% year over year to $7.9 billion, supported by broad-based gains across its Medline Brand and Supply Chain Solutions businesses.…
benzinga.com Medline Q3 2026 Earnings Call Transcript Medline (NASDAQ:MDLN) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
zacks.com Medline (MDLN) Reports Q3 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for Medline (MDLN) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics…
benzinga.com Wayfair, Lendingtree, Bruker, Zimmer Biomet And Other Big Stocks Moving Higher On Wednesday U.S. stocks surged, led by Wayfair after strong results; Cricut, Array Technologies, Clear Secure and others also posted double-digit gains.benzinga.com Medline Announces $1B Buyback Plan Medline Inc. ("Medline" or the "Company") (NASDAQ:MDLN), the largest provider of medical-surgical ("med-surg") products and supply chain solutions serving all points of care, today announced its
benzinga.com Medline Q3 Adj. EPS $0.44 Beats $0.35 Estimate, Sales $7.856B Beat $7.723B Estimate Medline (NASDAQ:MDLN) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.35 by 25.71 percent. The company reported quarterly sales of $7.856 billion which…
globenewswire.com Medline Reports Third Quarter and Nine Months 2026 Results NORTHFIELD, Ill., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline” or the “Company”) (Nasdaq: MDLN), the largest provider of medical-surgical (“med-surg”) products and supply chain solutions…
globenewswire.com MDLN Investigation Reminder: Medline Product Quality Issues Trigger Securities Fraud Investigation for Investors – Contact BFA Law if You Lost Money NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
benzinga.com ARM, McDonald's On Deck Wednesday As AI Demand, Consumer Spending Face Test ARM Holdings headlines Wednesday’s reports, with investors looking for evidence that AI-related demand can support the chip designer after a sharp stock pullback. McDonald’s, Novo Nordisk, Uber…
globenewswire.com Medline announces participation in the 2026 Jefferies Global Healthcare Conference NORTHFIELD, Ill., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, chief executive officer, is scheduled to present at the Jefferies Global…
benzinga.com Earnings Volatility Watch: 10 Stocks Are Set to Swing More Than 10% This Week Ten stocks carry implied earnings moves above 10% next week, led by Moderna and AppLovin. Five are tech names hit in Friday's chip rout.
globenewswire.com MDLN Stock Market Alert: Medline Under Investigation for Potential Securities Fraud Over Product Quality Issues – Contact BFA Law if You Lost Money NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
prnewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). Such investors are advised to contact…
globenewswire.com $MDLN Stock Market Alert: Medline Investigated for Securities Fraud after Product Quality Issues Lead to 13% Stock Drop – Contact BFA Law if You Lost Money NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
globenewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN). Such investors are advised to…
globenewswire.com $MDLN Stock Losses: BFA Law Reminds Medline Investors with Losses of the Ongoing Securities Fraud Investigation into Potential Product Quality Misrepresentations NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
globenewswire.com MDLN Investigation News: Medline Investors are Notified of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
prnewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). Such investors are advised to contact…benzinga.com Mizuho Maintains Outperform on Medline, Lowers Price Target to $45 Mizuho analyst Steven Valiquette maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the price target from $48 to $45.
globenewswire.com MDLN Loss Notice: Medline Investors are Reminded of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
